ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/087/SRR14873287/SRR14873287_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/090/SRR14873290/SRR14873290_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/089/SRR14873289/SRR14873289_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/090/SRR14873290/SRR14873290_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/087/SRR14873287/SRR14873287_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/088/SRR14873288/SRR14873288_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/088/SRR14873288/SRR14873288_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR148/089/SRR14873289/SRR14873289_2.fastq.gzprimaryOK200GenomicsDepartment of Pharmacy, Shanghai Xuhui Central Hospital, Zhongshan-Xuhui Hospital, Fudan Universityhttps://www.ebi.ac.uk/ena/browser/view/PRJNA739744Homo sapiensWe systematically described the oncogenic functions of KAT2A in ccRCC Overall design: RNA-seq of WT and KAT2A KO ccRCC cells.ENAGcn5, mmGCN5, GCN5, clear cell renal cell carcinoma, Gcn5l2, clear cell renal cell adenocarcinoma, Epigenetic, hGCN5, GCN5L2, 1110051E14Rik, CCRCC., Epigenetics, regulator, Epigenomic, AW212720, PCAF-bGcn5, mmGCN5, GCN5, clear cell renal cell carcinoma, Gcn5l2, clear cell renal cell adenocarcinoma, Epigenetic, hGCN5, GCN5L2, 1110051E14Rik, CCRCC., Epigenetics, regulator, Epigenomic, AW212720, PCAF-bfalseInvestigations of the roles of epigenetic regulator KAT2A in ccRCCInvestigations of the roles of epigenetic regulator KAT2A in ccRCC2025-09-242021-06-23PRJNA739744GSE1786309606